Trial · NCT00481247
Results by group72
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 72
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Best Confirmed Complete Cytogenetic Response (cCCyR) Within 12 Months | Dasatinib | 204 | Participants | ||
| Number of Participants With Best Confirmed Complete Cytogenetic Response (cCCyR) Within 12 Months | Imatinib | 177 | Participants | ||
| Percentage of Participants Remaining in Confirmed Complete Cytogenetic Response (cCCyR) | Dasatinib | At Year 2 | 98.0 | 95% Confidence Interval 94.7 to 99.2 | percentage of participants |
| Percentage of Participants Remaining in Confirmed Complete Cytogenetic Response (cCCyR) | Imatinib | At Year 2 | 96.9 | 95% Confidence Interval 93.2 to 98.6 | percentage of participants |
| Percentage of Participants Remaining in Confirmed Complete Cytogenetic Response (cCCyR) | Dasatinib | At Year 3 | 96.9 | 95% Confidence Interval 93.3 to 98.6 | percentage of participants |
| Percentage of Participants Remaining in Confirmed Complete Cytogenetic Response (cCCyR) | Imatinib | At Year 3 | 95.7 | 95% Confidence Interval 91.6 to 97.8 | percentage of participants |
| Percentage of Participants Remaining in Confirmed Complete Cytogenetic Response (cCCyR) | Dasatinib | At Year 4 | 95.6 | 95% Confidence Interval 91.4 to 97.8 | percentage of participants |
| Percentage of Participants Remaining in Confirmed Complete Cytogenetic Response (cCCyR) | Imatinib | At Year 4 | 95.7 | 95% Confidence Interval 91.6 to 97.8 | percentage of participants |
| Percentage of Participants Remaining in Confirmed Complete Cytogenetic Response (cCCyR) | Dasatinib | At Year 5 | 93.1 | 95% Confidence Interval 86.5 to 96.5 | percentage of participants |
| Percentage of Participants Remaining in Confirmed Complete Cytogenetic Response (cCCyR) | Imatinib | At Year 5 | 91.0 | 95% Confidence Interval 83.6 to 95.2 | percentage of participants |
| Percentage of Participants With Major Molecular Response (MMR) at Any Time | Dasatinib | 76.4 | Percentage of participants | ||
| Percentage of Participants With Major Molecular Response (MMR) at Any Time | Imatinib | 64.2 | Percentage of participants | ||
| Time to Confirmed Complete Cytogenic Response (cCCyR) Overall | Dasatinib | 3.1 | 95% Confidence Interval 3.0 to 3.1 | Months | |
| Time to Confirmed Complete Cytogenic Response (cCCyR) Overall | Imatinib | 5.8 | 95% Confidence Interval 5.6 to 6.0 | Months | |
| Time to Major Molecular Response (MMR) Overall | Dasatinib | 9.3 | 95% Confidence Interval 8.8 to 11.8 | Months | |
| Time to Major Molecular Response (MMR) Overall | Imatinib | 15.0 | 95% Confidence Interval 12.2 to 18.2 | Months | |
| Percentage of Participants With Progression-free Survival (PFS) | Dasatinib | 88.9 | Percentage of participants | ||
| Percentage of Participants With Progression-free Survival (PFS) | Imatinib | 89.2 | Percentage of participants | ||
| Percentage of Participants With Overall Survival (OS) | Dasatinib | 90.9 | Percentage of participants | ||
| Percentage of Participants With Overall Survival (OS) | Imatinib | 89.6 | Percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00481247/results